1.
Andrew Chase, Catherine Bryant, Joannah Score, Nicholas C.P. Cross. Ponatinib as targeted therapy for FGFR1 fusions associated with the 8p11 myeloproliferative syndrome. haematol [Internet]. 2013Jan.1 [cited 2021Dec.1];98(1):103-6. Available from: https://haematologica.org/article/view/6521